8-K//Current report
NKGen Biotech, Inc. 8-K
Accession 0001213900-25-093062
$NKGNCIK 0001845459operating
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 4:05 PM ET
Size
281.2 KB
Accession
0001213900-25-093062
Documents
- 8-Kea0259029-8k_nkgen.htmPrimary
CURRENT REPORT
- EX-10.1ea025902901ex10-1_nkgen.htm
CONSULTING AGREEMENT, BY AND BETWEEN NKGEN BIOTECH, INC. AND YOUNGMAN KIM, DATED SEPTEMBER 25, 2025
- EX-101.SCHnkgn-20250925.xsd
XBRL SCHEMA FILE
- EX-101.DEFnkgn-20250925_def.xml
XBRL DEFINITION FILE
- EX-101.LABnkgn-20250925_lab.xml
XBRL LABEL FILE
- EX-101.PREnkgn-20250925_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-093062-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0259029-8k_nkgen_htm.xml
IDEA: XBRL DOCUMENT
Issuer
NKGen Biotech, Inc.
CIK 0001845459
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001845459
Filing Metadata
- Form type
- 8-K
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 4:05 PM ET
- Size
- 281.2 KB